Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-28
1996-04-09
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 82, A61K 31435, C07D47104
Patent
active
055062369
ABSTRACT:
The invention relates to compounds represented by formula 1a or 1b ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.1, R.sub.2, R.sub.3, R.sub.8, R.sub.9, and n are as described herein.
These compounds are useful as agents in treating herpes virus infections.
REFERENCES:
patent: 3600393 (1971-08-01), Graeve et al.
patent: 3790576 (1974-02-01), DeWald
patent: 4013665 (1977-03-01), Crenshaw
patent: 4757088 (1988-07-01), Haines
patent: 4920128 (1990-04-01), Bell
Crenshaw et al., Journal of Medicianl Chemistry, 1976, vol. 19, No. 2, pp. 262-275.
Czechoslovak Pharmacy 34(3-4) pp. 119-122 (1985) and English translation thereof.
Afonso Adriano
Chackalamannil Samuel
Kelly Joseph M.
Boxer Matthew
Chang Ceila
Schering Corporation
LandOfFree
4-substituted pyrazoloquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-substituted pyrazoloquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-substituted pyrazoloquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139241